未登录

S

Silvia Millán-Martín

national institute for bioprocessing research and training

H指数:20

被引数:1,412

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Compliance-ready workflow for antisense oligonucleotides impurity analysis without ion pairing agents

合规性工作流程：无需离子对试剂的反义寡核苷酸杂质分析

Journal of Pharmaceutical and Biomedical Analysis

IF3.1

2026-09-240

PRE

High-sensitivity MAM to support early-stage activities during biotherapeutic development

高灵敏度MAM以支持生物治疗药物开发过程中的早期活动

Journal of Chromatography A

IF4

2026-03-030

OAAI

Characterisation of small RNA-based therapeutics and their process impurities by fast and sensitive liquid chromatography high resolution mass spectrometry

基于小RNA的疗法及其工艺杂质的表征：通过快速、高灵敏度的液相色谱高分辨质谱法

Journal of Pharmaceutical and Biomedical Analysis

IF3.1

2025-08-120

OAAI

Development of a Rapid Adeno-Associated Virus (AAV) Identity Testing Platform through Comprehensive Intact Mass Analysis of Full-Length AAV Capsid Proteins

JOURNAL OF PROTEOME RESEARCH

IF3.6

2023-12-206

OAAI

Cation exchange chromatography on a monodisperse 3 μm particle enables extensive analytical similarity assessment of biosimilars

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2023-09-012

OAAI

Exploring proteoforms of the IgG2 monoclonal antibody panitumumab using microchip capillary electrophoresis-mass spectrometry

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2023-09-014

OAAI

Multi-attribute method (MAM) to assess analytical comparability of adalimumab biosimilars

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2023-09-017

OAAI

Multi-Attribute Method (MAM): An Emerging Analytical Workflow for Biopharmaceutical Characterization, Batch Release and cGMP Purity Testing at the Peptide and Intact Protein Level

CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY

IF5.2

2023-07-2513

OA

Comprehensive multi-attribute method workflow for biotherapeutic characterization and current good manufacturing practices testing

NATURE PROTOCOLS

IF16

2022-12-1615

PRE

Fast and efficient digestion of adeno associated virus (AAV) capsid proteins for liquid chromatography mass spectrometry (LC-MS) based peptide mapping and post translational modification analysis (PTMs)

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2022-01-0122

OAAI

2-Dimensional ultra-high performance liquid chromatography and DMT-MM derivatization paired with tandem mass spectrometry for comprehensive serum N-glycome characterization

ANALYTICA CHIMICA ACTA

IF6

2021-09-011

OAAI

A novel HPLC-MS/MS approach for the identification of biological thiols in vegetables

IF9.8

2021-03-0111

PREAI

Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

IF2.7

2021-01-2938

OAAI

Inline electrochemical reduction of NISTmAb for middle-up subunit liquid chromatography-mass spectrometry analysis

IF3.3

2021-01-017

OA

Inter-laboratory study of an optimised peptide mapping workflow using automated trypsin digestion for monitoring monoclonal antibody product quality attributes

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2020-07-2540

OAAI

Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies

JOURNAL OF PHARMACEUTICAL ANALYSIS

IF8.9

2020-02-0140

OAAI

Expression, Purification, and Biochemical Characterization of Human Afamin

JOURNAL OF PROTEOME RESEARCH

IF3.6

2018-02-208

PREAI

Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab

MOLECULAR & CELLULAR PROTEOMICS

IF5.5

2017-10-0159

OAAI

Advances in analytical methodologies to guide bioprocess engineering for bio-therapeutics

IF4.3

2017-03-0112

PREAI

Twoplex 12/13 C6 aniline stable isotope and linkage-specific sialic acid labeling 2D-LC-MS workflow for quantitative N-glycomics

IF3.9

2017-01-1811

PREAI